Panacea Index Logo

Command Palette

Search for a command to run...

Melatonin stimulates VEGF expression in human granulosa-lutein cells: A potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.

Molecular and cellular endocrinology
January 1, 1970
Yiran Li et al. (9 authors)
Journal ArticleResearch Support, Non-U.S. Gov'tHuman StudyAnimal StudyMolecular Study
Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
melatonin
increase
VEGF expression
human granulosa-lutein (hGL) cells
-
stimulates
#1
melatonin
increase
VEGF expression
human granulosa-lutein (hGL) cells
-
induces
#2
MT2 receptor and activation of AKT
neutral
melatonin-induced VEGF expression
human granulosa-lutein (hGL) cells
-
are involved in
#3
OHSS
increase
VEGF levels
ovaries of OHSS rats
-
up-regulated
#4
Blocking the melatonin system by administrating MT2 receptor antagonist, 4-P-PDOT
decrease
OHSS symptoms
rat OHSS model
-
alleviates
#5
Blocking the melatonin system by administrating MT2 receptor antagonist, 4-P-PDOT
decrease
expression of VEGF
rat OHSS model
-
decreasing
#6
OHSS
increase
expression levels of melatonin and VEGF
follicular fluid of OHSS patients
-
up-regulated
#7
melatonin
increase
VEGF
follicular fluid of OHSS patients
-
positively correlated
#8
Abstract

Melatonin can be synthesized and secreted not only by the pineal gland but also by many extra-pineal tissues. It has been shown that many ovarian functions are regulated by melatonin locally. Ovarian hyperstimulation syndrome (OHSS) is a serious complication during ovulation induction of the in vitro fertilization treatment. To date, the etiology of OHSS is not fully understood. However, vascular endothelial growth factor (VEGF) is recognized as a critical mediator for the pathogenesis of OHSS. High expression of melatonin has been detected in the follicular fluid of OHSS patients. However, whether VEGF expression can be regulated by melatonin in human granulosa cells and further contributes to the pathogenesis of OHSS remain unknown. In this study, we show that melatonin stimulates VEGF expression in human granulosa-lutein (hGL) cells. Our results reveal that the MT2 receptor and activation of AKT are involved in melatonin-induced VEGF expression. Using a rat OHSS model, we report that the VEGF levels are up-regulated in the ovaries of OHSS rats. Blocking the melatonin system by administrating MT2 receptor antagonist, 4-P-PDOT, alleviates OHSS symptoms by decreasing the expression of VEGF. In addition, the expression levels of melatonin and VEGF in the follicular fluid of OHSS patients are up-regulated and positively correlated. This study demonstrates an important role for melatonin in regulating the pathogenesis of OHSS.

Medical Subject Headings (MeSH)
AnimalsCells, CulturedDisease Models, AnimalFemaleHumansLuteal CellsMelatoninOvarian Hyperstimulation SyndromePrimary Cell CultureProto-Oncogene Proteins c-aktRatsReceptor, Melatonin, MT2Signal TransductionTetrahydronaphthalenesUp-RegulationVascular Endothelial Growth Factor A
Study Links
PubMed ID32791190
Related Supplements
Melatonin stimulates VEGF expression in human granulosa-lute... | Panacea Index